{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:44:49Z","timestamp":1768779889795,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09418"],"award-info":[{"award-number":["17K09418"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.dld.2021.02.013","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T00:55:23Z","timestamp":1615683323000},"page":"1443-1450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine"],"prefix":"10.1016","volume":"53","author":[{"given":"Kenta","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Kuzuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko M.","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.02.013_bib0001","first-page":"e9302","article-title":"The role of the microbiome in NAFLD and NASH","author":"Kolodziejczyk","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.dld.2021.02.013_bib0002","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC \u2013 Mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.02.013_bib0003","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.dld.2021.02.013_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.02.013_bib0005","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.dld.2021.02.013_bib0006","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/liv.14362","article-title":"Natural history of NASH and HCC","volume":"40","author":"Negro","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.02.013_bib0007","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.dld.2021.02.013_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020308","article-title":"Intestinal microbiota protects against MCD diet-induced steatohepatitis","volume":"20","author":"Schneider","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.dld.2021.02.013_bib0009","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1136\/gutjnl-2019-318491","article-title":"Gut microbiota shape \u201cinflamm-ageing\u201d cytokines and account for age-dependent decline in DNA damage repair","volume":"69","author":"Guedj","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.dld.2021.02.013_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.dld.2021.02.013_bib0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cbi.2019.02.024","article-title":"Diethylnitrosamine enhances hepatic tumorigenic pathways in mice fed with high fat diet (Hfd)","volume":"303","author":"Arboatti","year":"2019","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.dld.2021.02.013_bib0012","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/1097-0142(20010101)91:1<106::AID-CNCR14>3.0.CO;2-2","article-title":"Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma","volume":"91","author":"Yuen","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.dld.2021.02.013_bib0013","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molmet.2019.10.002","article-title":"Metabolic functions of the tumor suppressor p53: implications in normal physiology, metabolic disorders, and cancer","volume":"33","author":"Lacroix","year":"2019","journal-title":"Mol. Metab."},{"key":"10.1016\/j.dld.2021.02.013_bib0014","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jhep.2014.10.024","article-title":"Dietary effects on liver tumor burden in mice treated with the hepatocellular carcinogen diethylnitrosamine","volume":"62","author":"Healy","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.02.013_bib0015","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2012.05.013","article-title":"P53\/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice","volume":"57","author":"Tomita","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.02.013_bib0016","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/hep.30098","article-title":"Hepatitis B virus\u2013upregulated LNC-HUR1 promotes cell proliferation and tumorigenesis by blocking p53 activity","volume":"68","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.02.013_bib0017","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"P21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.dld.2021.02.013_bib0018","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","article-title":"Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression","volume":"24","author":"Farrell","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.02.013_bib0019","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1074\/jbc.M400884200","article-title":"p53 Involvement in the pathogenesis of fatty liver disease","volume":"279","author":"Yahagi","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.dld.2021.02.013_bib0020","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-0030-1255353","article-title":"Toll-like receptor 4 and hepatic fibrogenesis","volume":"30","author":"Pradere","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.dld.2021.02.013_bib0021","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.dld.2021.02.013_bib0022","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.dld.2021.02.013_bib0023","first-page":"1","article-title":"Pasteurized Akkermansia muciniphila increases whole-body energy expenditure and fecal energy excretion in diet-induced obese mice","author":"Depommier","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.dld.2021.02.013_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2019.02.001","article-title":"The role of gut microbiota in liver disease development and treatment","volume":"3","author":"Wang","year":"2019","journal-title":"Liver Res"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:18:58Z","timestamp":1761625138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1590865821000815"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.02.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome, fibrosis and tumor networks in a non-alcoholic steatohepatitis model of a choline-deficient high-fat diet using diethylnitrosamine","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}